NASDAQ:SRPT - Sarepta Therapeutics Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $118.09 +4.30 (+3.78 %) (As of 04/24/2019 06:00 AM ET)Previous Close$113.79Today's Range$112.54 - $118.326052-Week Range$74.51 - $176.50Volume1.31 million shsAverage Volume1.33 million shsMarket Capitalization$8.42 billionP/E RatioN/ADividend YieldN/ABeta2.04 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Sarepta Therapeutics (NASDAQ:SRPT) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.28 Wall Street analysts have issued ratings and price targets for Sarepta Therapeutics in the last 12 months. Their average twelve-month price target is $195.0476, suggesting that the stock has a possible upside of 65.17%. The high price target for SRPT is $270.00 and the low price target for SRPT is $121.00. There are currently 2 hold ratings and 26 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.932.932.922.92Ratings Breakdown: 0 Sell Rating(s)2 Hold Rating(s)26 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)2 Hold Rating(s)25 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)2 Hold Rating(s)23 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)2 Hold Rating(s)23 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $195.0476$193.90$184.2857$169.3414Price Target Upside: 65.17% upside44.28% upside52.39% upside39.42% upsideSarepta Therapeutics (NASDAQ:SRPT) Consensus Price Target History Sarepta Therapeutics (NASDAQ:SRPT) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails4/17/2019BTIG ResearchSet Price TargetBuy$190.00High4/11/2019Evercore ISIInitiated CoverageOutperform$175.00High3/31/2019CowenReiterated RatingBuy$213.00Low3/28/2019Piper Jaffray CompaniesBoost Price TargetOverweight$200.00 ➝ $208.00Low3/12/2019BMO Capital MarketsInitiated CoverageOutperformLow3/11/2019Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$189.00 ➝ $207.00Low3/5/2019Svb LeerinkReiterated RatingOutperformLow3/4/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$161.00 ➝ $169.00Low3/1/2019CitigroupBoost Price TargetBuy ➝ Buy$188.00 ➝ $201.00Low2/28/2019NomuraBoost Price TargetBuy ➝ Buy$205.00 ➝ $230.00Low2/28/2019Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$217.00 ➝ $231.00High2/27/2019JMP SecuritiesReiterated RatingBuy$270.00High1/17/2019Royal Bank of CanadaReiterated RatingOutperform$164.00Low1/8/2019Janney Montgomery ScottSet Price TargetBuy$200.00Medium1/4/2019HC WainwrightSet Price TargetBuy$267.00High10/12/2018Sanford C. BernsteinInitiated CoverageOutperform$170.00High9/24/2018Needham & Company LLCLower Price TargetBuy$196.00Low9/14/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$199.00Low6/22/2018SunTrust BanksBoost Price TargetBuy$176.00High6/21/2018Robert W. BairdReiterated RatingOutperform ➝ Outperform$120.00 ➝ $202.00Medium6/20/2018WBB SecuritiesReiterated RatingBuyLow6/20/2018Leerink SwannReiterated RatingOutperform ➝ OutperformHigh6/20/2018BarclaysReiterated RatingOverweight$180.00High6/19/2018William BlairReiterated RatingBuyHigh6/19/2018JPMorgan Chase & Co.Reiterated RatingOverweightHigh5/18/2018Goldman Sachs GroupBoost Price TargetBuy$84.00 ➝ $127.00Low5/4/2018OppenheimerDowngradeOutperform ➝ Market PerformHigh5/4/2018UBS GroupDowngradeOutperform ➝ Market PerformHigh10/2/2017InstinetReiterated RatingBuy$84.00Low(Data available from 4/24/2017 forward) This page was last updated on 4/24/2019 by MarketBeat.com StaffFeatured Article: Why are gap-down stocks important?